Navigation Links
Study Results Show That Minimally Invasive Therapy is Successful for Over Two-Thirds of Stroke Patients Treated Outside the Standard Eight-Hour Window
Date:7/30/2009

Findings May Potentially Lead to New Approach to Stroke Treatment

BOCA RATON, Fla., July 30 /PRNewswire-USNewswire/ -- When minimally invasive endovascular (through the vessel) therapy made its debut two decades ago, stroke care underwent a major shift as the "window of treatment" for patients suffering a stroke was expanded to eight hours within symptom onset, rather than the standard three-hour window required by the FDA-approved intravenous tPA therapy. Now, a new retrospective, multi-center study shows that endovascular therapy beyond the eight-hour window restored blood flow in the brain in approximately 74 percent of patients suffering ischemic (caused by a clot) stroke. Presented today at the Society of NeuroInterventional Surgery (SNIS) 6th Annual Meeting in Boca Raton, FL, the data suggests that this treatment is safe and potentially leads to improved outcomes for a select number of late-presenting patients, including those who awake with stroke symptoms.

According to lead author Raul Nogueira, M.D., Assistant in Neurology and Radiology at Massachusetts General Hospital -- Harvard Medical School, presentation beyond eight hours of symptom onset has traditionally been the single most important factor in excluding patients from stroke treatment. Thus, continued Nogueira, when brain imaging studies revealed that a significant number of late-presenting stroke patients showed evidence of salvageable brain tissue in the area of the stroke, it was an important avenue to pursue. This meant that endovascular therapy (performed by neurointerventional specialists who use drugs or mechanical devices inserted through a catheter or narrow tube that is threaded up through the vessels directly to the problem site to dispel the clot) could potentially be utilized successfully in these patients.

"As we considered the possibilities, it became an exciting proposit
'/>"/>

SOURCE Society of NeuroInterventional Surgery
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Study Shows Cancer Vaccines Led to Long-Term Survival for Patients with Metastatic Melanoma and to Long Periods of Disease Control After Completion of Therapy
2. Cyberonics Provides Update on Depression Post-Approval Study
3. NeurogesX Announces Preliminary Results of FDA-Requested Qutenza(TM) Study
4. R-Tech Ueno, Ltd. Completes Phase 1 Clinical Study on RK-023
5. UPDATE: US Oncology Research Network Participates in Phase III Follow-up Study to BiPars Investigational Cancer Drug BSI-201
6. Idenix Pharmaceuticals Successfully Completes Proof-of-Concept Study of IDX184 for the Treatment of Hepatitis C Virus (HCV)
7. Exenatide Once Weekly Provided Superior Glucose Control Compared to Lantus(R) in Head-to-Head DURATION-3 Study
8. Prospective Clinical Advantages of Trabecular Metal(TM) Technology Highlighted in Comparative Study
9. New Results From ARTEN Study of Nevirapine Plus Tenofovir and Emtricitabine (TDF/FTC) Versus Boosted Protease Inhibitor Regimen of Atazanavir/Ritonavir Plus TDF/FTC Revealed
10. Cytokine PharmaSciences Initiates Phase I Study of Oral Anti-Inflammatory Agent, CPSI-2364
11. Human Genome Sciences and GlaxoSmithKline Announce Positive Phase 3 Study Results for BENLYSTA(TM) in Systemic Lupus Erythematosus
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/31/2015)... Calif. , Aug. 31, 2015  Regulatory ... and government, where regulations are often strict and ... is driving a demand for professionals who have ... these regulations across a product lifecycle and demonstrate ... The University of California, Irvine Extension , ...
(Date:8/31/2015)... , Aug. 31, 2015 Regen BioPharma, ... development of a novel means of delivering its ... RGBP-248, to liver tumors utilizing a clinically approved ... overcomes previous hurdles with gene silencing therapeutics in ... delivered throughout the whole body.  By utilizing a ...
(Date:8/31/2015)... MOUNTAIN VIEW, Calif. , Aug. 31, ... EURONEXT: SAN) and the life sciences team at Google ... and outcomes for people with type 1 and type ... and devices with Google,s expertise in analytics, miniaturized electronics ... how to improve diabetes care by developing new tools ...
Breaking Medicine Technology:UC Irvine Extension Launches New Regulatory Affairs and Compliance Certificate Program 2UC Irvine Extension Launches New Regulatory Affairs and Compliance Certificate Program 3Regen BioPharma, Inc. Develops BORIS Gene Silencing Based Treatment for Unresectable Liver Cancer 2Regen BioPharma, Inc. Develops BORIS Gene Silencing Based Treatment for Unresectable Liver Cancer 3Sanofi to Collaborate with Google Life Sciences to Improve Diabetes Health Outcomes 2Sanofi to Collaborate with Google Life Sciences to Improve Diabetes Health Outcomes 3Sanofi to Collaborate with Google Life Sciences to Improve Diabetes Health Outcomes 4Sanofi to Collaborate with Google Life Sciences to Improve Diabetes Health Outcomes 5Sanofi to Collaborate with Google Life Sciences to Improve Diabetes Health Outcomes 6
(Date:8/31/2015)... ... September 01, 2015 , ... Neuropsychiatric Disease and ... emphasis on transcranial near-infrared laser phototherapy ”. , As corresponding author Dr Theodore ... largely untreatable - with mostly palliative treatments only - and now we have ...
(Date:8/31/2015)... (PRWEB) , ... August 31, 2015 , ... Since 1946, ... patient-oriented dental care. From the moment a patient arrives at the office, the ... Tuckman will work with each and every patient to create a complete dental treatment ...
(Date:8/31/2015)... Aliso Viejo, CA (PRWEB) , ... August 31, 2015 , ... With the FCPX LUT ... to footage. A LUT is a Lookup Table that contains a mathematical formula for modifying ... table. This pack comes with 60 soft CUBE LUT files. , FCPX LUT Soft requires ...
(Date:8/31/2015)... ... 31, 2015 , ... According to an article published August 3rd ... adolescents who underwent bariatric surgery “felt significantly better two years after surgery.” The article ... in the study felt that their “mental health had been normalized” at the point ...
(Date:8/31/2015)... ... 31, 2015 , ... The dental implant and prosthetic market in the U.S. ... Dentistry. (See Press Room ) More than 30 million Americans are missing all ... increasing demand for dental implants, the National Association of Dental Laboratories (NADL) created the ...
Breaking Medicine News(10 mins):Health News:Near-Infrared Laser Phototherapy for Brain Injury published by Dove Medical Press 2Health News:Near-Infrared Laser Phototherapy for Brain Injury published by Dove Medical Press 3Health News:NJ Top Dentists Presents, Clifton Dental Associates! 2Health News:Pixel Film Studios, FCPX Plugin Developer, Releases FCPX LUT Soft 2Health News:Article on Adolescent Bariatric Surgery Demonstrates the Powerful Effect of Being in Control, Notes Dr. Michael Feiz 2Health News:Article on Adolescent Bariatric Surgery Demonstrates the Powerful Effect of Being in Control, Notes Dr. Michael Feiz 3Health News:Dental Association Raises Awareness as Implant Industry Grows 2Health News:Dental Association Raises Awareness as Implant Industry Grows 3Health News:Dental Association Raises Awareness as Implant Industry Grows 4
... PRA International, a leading Clinical Research Organization, announces ... Sao Paulo, Brazil office. Drug Safety Centers are a ... They are staffed with drug safety professionals who are ... management. Furthermore, our drug safety personnel support our ...
... Nuvilex, Inc. (OTC Bulletin Board: NVLX), an emerging ... world,s first permanent tattoo ink designed to be both ... a June 1st article in Time Magazine. The ... Infinitink, a product developed to address tattoo regret and ...
... FOR ORAL MUCOSITIS , DALLAS, May 27 ... (OTC Bulletin Board: ACCP) , ( http://www.accesspharma.com ... MuGard(TM) , its proprietary oral mucositis ... Nordic countries by its European commercial partner, SpePharm ...
... study finds, , , , WEDNESDAY, May 27 (HealthDay News) ... been identified by U.S. researchers, who said their finding ... The researchers, from the Washington University School of Medicine ... ATR gene in tumors boosts the risk of cancer ...
... a privately held international health care consulting group, announced ... The Sage Group to include, in addition to the ... for Chronic Fatigue Syndrome *, additional partnering efforts ... preventative pandemic flu vaccines and the additional role of ...
... Millennium Research Group,s new European dental implant report now ... 27 Millennium Research Group,s (MRG,s) new European ... despite unfavorable economic conditions, the market was valued at ... over $2.7 billion by 2013 as new technologies drive ...
Cached Medicine News:Health News:PRA International Opens Additional Drug Safety Center in Sao Paulo, Brazil 2Health News:PRA International Opens Additional Drug Safety Center in Sao Paulo, Brazil 3Health News:Time Magazine Reports on Infinitink Tattoo Ink From Nuvilex 2Health News:Time Magazine Reports on Infinitink Tattoo Ink From Nuvilex 3Health News:Access Pharmaceuticals Provides Update on Global Launch of MuGard(TM) 2Health News:Access Pharmaceuticals Provides Update on Global Launch of MuGard(TM) 3Health News:Gene Mutation May Up Risks of Endometrial Cancer 2Health News:The Sage Group Widens Strategic Role to Assist HemispherX Biopharma in Pandemic Influenza Initiatives as Pacific Rim/Japan Treatment/Prevention Programs Accelerate 2Health News:The Sage Group Widens Strategic Role to Assist HemispherX Biopharma in Pandemic Influenza Initiatives as Pacific Rim/Japan Treatment/Prevention Programs Accelerate 3Health News:The Sage Group Widens Strategic Role to Assist HemispherX Biopharma in Pandemic Influenza Initiatives as Pacific Rim/Japan Treatment/Prevention Programs Accelerate 4Health News:Increasingly Competitive European Dental Implant Market to Reach Over $2.7 Billion by 2013 Despite Unfavorable Economic Conditions 2Health News:Increasingly Competitive European Dental Implant Market to Reach Over $2.7 Billion by 2013 Despite Unfavorable Economic Conditions 3
6.3X Zoom Ratio - Boasting magnifications from 0.8X to 5X, the twin zooming objective optical system developed exclusively by Nikon provides a zoom ratio of 6.3:1. Clickstops at 1X intervals allow ob...
... With a zoom ratio of ... 0.75X to 11.25X, and the ... intervals from 1X to 11X, ... Magnifications of 3.75X to 540X ...
Inquire...
Fluar objectives have been designed especially for qualitative and quantitative analyses of ion movements and for particularly critical fluorescence methods (e.g. chromosome studies in human and cyto...
Medicine Products: